181.
Health and economic burden of the projected obesity trends in the USA and the UK
by Wang, Y Claire, MD
The Lancet (British edition), 2011, Vol.378 (9793), p.815-825
182.
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
by Jiang, Ying
European journal of epidemiology, 2011, Vol.26 (11), p.863-876
183.
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies
by Li, Donghui
Cancer causes & control, 2011, Vol.22 (2), p.189-197
184.
185.
Diabetes Burden and Diabetes Distress: the Buffering Effect of Social Support
by Baek, Rachel N
Annals of behavioral medicine, 2014, Vol.48 (2), p.145-155
186.
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
by Home, P. D
Diabetologia, 2009, Vol.52 (12), p.2499-2506
187.
Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models
by Chen, Fang
Diabetologia, 2015, Vol.59 (2), p.316-324
188.
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk
by VESTERGAARD, P
Diabetologia, 2005, Vol.48 (7), p.1292-1299
189.
Type 2 diabetes in midlife and risk of cerebrovascular disease in late life: a prospective nested case−control study in a nationwide Swedish twin cohort
by Yang, Rongrong
Diabetologia, 2019, Vol.62 (8), p.1403-1411
190.
Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline
by Copeland, Kenneth C
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (1), p.159-167
191.
Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study
by Lee, Alexandra K
Diabetologia, 2018, Vol.61 (9), p.1956-1965
192.
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
by Rigato, Mauro
The journal of clinical endocrinology and metabolism, 2015, Vol.100 (7), p.2666-2672
193.
Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
by Zhang, Zhi-Jiang
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (7), p.2347-2353
194.
The hormone resistin links obesity to diabetes
by Lazar, Mitchell A
Nature (London), 2001, Vol.409 (6818), p.307-312
195.
The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk
by Martins-Mendes, Daniela
Journal of diabetes and its complications, 2014, Vol.28 (5), p.632-638
196.
Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
by Fioretto, Paola
Diabetologia, 2016, Vol.59 (9), p.2036-2039
197.
Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity
by Tonks, Katherine T
The journal of clinical endocrinology and metabolism, 2017, Vol.102 (4), p.1112-1121
198.
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
by Keech, A
The Lancet (British edition), 2005, Vol.366 (9500), p.1849-1861
199.
Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes
by Rhee, Nicolai A
Diabetologia, 2015, Vol.58 (10), p.2254-2258
200.
Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality among Patients with Type 2 Diabetes Mellitus
by Tang, Huilin, MSc
The American journal of cardiology, 2016, Vol.118 (11), p.1774-1780
